Planktonic and young bioSlm cells were completely eradicated after exposure of these cells to drug levels representing one loading and two maintenance doses of tobramycin and cephalexin. A very different picture was observed when antibiotic exposure was initiated on day 21. Complete eradication of the old biofilm cells was not observed even when the antibiotic exposure was continued for an extra 6 days. Regrowth of the organism was observed when the antibiotic exposure was terminated.
The implantation of a variety of medical devices, such as urinary catheters and cardiac pacemakers, has become an integral part of therapeutic strategies in modem medical care. The use of these devices has created problems related to clinical infections. The devices are frequently colonized by bacteria which form biofilms (7, 8, 10, 12-15, 20, 21) . Skin floras such as Staphylococcus aureus and Staphylococcus epidermidis from patients and health care professionals have been shown to be implicated in these infections (7, 8, 10, 21) . Millions of dollars are spent annually on antibiotics to deal with biofilm-associated infections, but the results are often disappointing (6, 10, 12, 16, 17) . The antibiotics do not eradicate the bacteria colonizing the medical devices, which must therefore be removed. Quite often death occurs before this can be accomplished.
An in vitro chemostat system in which bacteria can be cultivated as biofilms at a low growth rate under conditions of iron restriction has been developed to investigate the interaction of bacteria in biofilms with antibiotics (1) (2) (3) (4) (5) . By using this system, it was found that the planktonic cells of Pseudomonas aeruginosa were susceptible to piperacillin and tobramycin. Young biofilm cells (harvested on day 2) were still susceptible to these agents, whereas old biofilm cells (harvested on day 7) were very resistant to these antibiotics. Higher concentrations of piperacillin and tobramycin were required to eradicate the old biofilm cells of P. aeruginosa (1, 3) .
In the studies mentioned above (1, (3) (4) (5) , the experiments were carried out by removing the biofilms on inert surfaces from the chemostat and exposing them to fixed concentrations of antibiotics for 5 to 6 h (1, 3-5). The time-killing curves were then constructed to reveal the susceptibilities of bacteria in biofilms to antibiotics (1, (3) (4) (5) . This exercise has provided us with information on the interaction of biofilm cells with the single dose of antibiotics required for their eradication. At this stage, we believe that it would be more useful to design an experiment in which the dynamic interaction of multiple doses of antibiotics with bacteria in biofilms for the duration of chemotherapy could be addressed. In this article, we report the kinetic interaction of biofilm cells of S. aureus with cephalexin and tobramycin. The usefulness of this system in the evaluation of the * Corresponding author. effectiveness of antibiotics in the eradication of bacteria in biofilms is discussed.
S. aureus R-627 isolated from an infected Tenckhoff catheter was grown in iron-depleted brain heart infusion (BHI-Fe) broth containing added mono-and divalent cations (11) in chemostats as described previously (1, (3) (4) (5) . One hundred pieces of 1-cm-long (size 16) Masterflex silicone tubing (Cole-Parmer Instrument Ltd., Chicago, Ill.) were incorporated into the chemostat culture for cell attachment and biofilm formation. A 5-ml sample of S. aureus grown to mid-exponential phase in BHI-Fe broth was inoculated into the chemostat. Fresh BHI-Fe medium was fed into the chemostat with a peristaltic pump to give a dilution rate of 0.17 h-1 (one volume change occurred every 6 h).
Viable counts of planktonic cells in the suspension were determined with serially diluted samples incubated on blood agar (Difco, Detroit, Mich.). To determine the number of biofilm cells that adhered on silicone tubing, the tubing was removed, washed three times with 10 ml of phosphatebuffered saline (PBS) to remove nonadherent cells, and then placed in 1 ml of PBS. The contents were vortex mixed for 3 min, and the serially diluted samples were incubated on blood agar (Difco) at 37°C.
On day 2 (young biofilm) or day 21 (old biofilm), tobramycin and cephalexin representing the loading dose (i.e., initial dose of antibiotics) were added to the chemostat cultures containing planktonic and biofilm cells so that the concentrations of these antibiotics were 70 and 500 ,ug per ml, respectively. These concentrations of antibiotics were chosen because high concentrations of antibiotics are often incorporated directly into the peritoneal fluid in the treatment of peritonitis in patients with peritoneal catheters t20, 21). The dilution rate of the chemostat was set to 0.17 h-so that one volume change of BHI-Fe medium in the chemostat occurred every 6 h. Samples were removed at hourly intervals for 6 h, and viable counts were obtained for both the planktonic and the biofilm cells by plating them onto blood agar and incubating them at 37°C. At 6 h, drug levels representing the maintenance doses of these agents (62.5 ,ug of tobramycin per ml and 250 ,g of cephalexin per ml) were added to the chemostat, and the viable counts were determined before the addition of the next dose. The addition of these antibiotics to the chemostat cultures was repeated at 6-h intervals for 7 days. On day 7 (after the initiation of antibiotic exposure), the antibiotic treatment was terminated, and fresh BHI-Fe medium was continuously pumped 1 The interaction of young and old biofilm cells of S. aureus with the kinetically controlled loading-dose combination of tobramycin (70 ,ug/ml) and cephalexin (500 ,ug/ml) is illustrated in Fig. 1A and B, respectively. The planktonic and young biofilm cells of the 2-day-old chemostat culture were found to be very susceptible to the drug levels representing the loading-dose combination of tobramycin and cephalexin (Fig. 1A) . The percent viable planktonic cells was reduced from 100 to approximately 0.0002% following exposure to these antibiotics for 6 h (Fig. 1A) . The young biofilm cells showed a very similar degree of susceptibility. The percent viable young biofilm cells was reduced from 100 to approximately 0.005% following exposure to these doses of antibiotics for 6 h (Fig. 1A) .
From Fig. 1B , it can be seen that the planktonic cells of this 21-day-old chemostat culture were still susceptible to these doses of tobramycin and cephalexin. The percent viable planktonic cells was reduced from 100 to approximately 0.0005% following exposure to these antibiotics. However, the old biofilm cells of the 21-day-old chemostat culture were more resistant to these doses of antibiotics (Fig.  1B) drug levels representing the loading and maintenance doses of tobramycin and cephalexin is illustrated in Fig. 2 . The first dose of these antibiotics (70 ,ug of tobramycin and 500 ,ug of cephalexin per ml) was called the loading dose, and the second dose (62 ,g of tobramycin and 250 ,ug of cephalexin per ml) was designated the maintenance dose. The viability of the planktonic cells dropped to approximately 0.0001% after exposure to the same concentrations of these agents for the same period. None of the young biofilm cells were found to be viable after exposure to the second maintenance doses of these antibiotics. However, the antibiotic administration was continued for 7 days, as this is routinely carried out in hospitals for the control of infection. No viable cells (either planktonic or young biofilm cells) could be detected in the chemostat for this period. The viability of the planktonic and young biofilm cells was monitored for 3 days after termination of antibiotic administration on day 7. Again, no viable cells could be detected, indicating complete eradication of planktonic and young biofilm cells.
The kinetic interaction of planktonic and old biofilm cells of the 21-day-old chemostat culture with tobramycin and cephalexin at levels representing the loading and maintenance doses is shown in Fig. 3 The problems associated with in vitro antimicrobial susceptibility tests have recently been discussed (18) . We believe that the interaction of bacterial pathogens with antibiotics in vivo is profoundly different from interactions observed in the in vitro susceptibility tests. In the in vitro susceptibility tests, the planktonic cells grown in complex laboratory medium are exposed to fixed concentrations of antibiotics. Planktonic cells are accessible to the antibiotics in the test tube, and the cells are killed instantaneously. A very different picture is observed in the interaction of pathogens with antibiotics in vivo. Antibiotics have access to planktonic cells and also biofilm cells that are located on the upper regions of biofilms. However, they do not have easy access to the biofilm cells that are deeply embedded in the glycocalyx matrix (1) (2) (3) (4) (5) (6) . Therefore, these biofilm cells may have sufficient time to turn on the expression of antibiotic resistance factors such as ,B-lactamases (9) to counteract the presence of antibiotic molecules. Another factor that has not been taken into account in the experimental design of in vitro antimicrobial susceptibility tests is the kinetic interaction of antibiotics with bacterial cells. The concentrations of antibiotics in vivo are dependent on the rate of clearance of the antibiotics from the body, and this should be considered in the experimental design to evaluate the effectiveness of antibiotics in the eradication of bacterial pathogens. This factor is important because it determines the number of antibiotic molecules that are available to interact with bacteria in biofilms at any given moment. We believe that studies on the kinetic interaction of biofilm cells with antibiotics will give us some valuable insight into the dosage and frequency of antibiotic administration that should be used in the eradication of bacteria in biofilms. In this study, these antibiotics were added directly into the chemostat, as they are often added directly into the peritoneal fluid in clinical practice. Fresh antibiotic-free medium was then pumped into the chemostat at a rate determined by the pharmacokinetics of the antibiotics so that the peak and trough levels of the antibiotics could be simulated.
From this study, it can be seen that the planktonic and young biofilm cells of the 2-day-old chemostat culture can be effectively eradicated by the loading and maintenance doses of tobramycin and cephalexin (Fig. 2) . From analysis of the data, we observe that the planktonic and young biofilm cells are completely eradicated after exposure of these cells to one loading and two maintenance doses of these antibiotics. Regrowth of the organism does not occur after the antibiotic treatment is terminated on day 7 (Fig. 2) . Combinations of antibiotics with synergistic activities should be considered, and the concentrations of the antibiotics have to be sufficiently high to ensure complete eradication of the organism. Any delay in implementing antibiotic therapy may result in failure of the treatment.
A very different picture is observed when antibiotic treatment is initiated on day 21. We still observe a rapid decrease in the cell viability when the planktonic and old biofilm cells are exposed to the loading dose of tobramycin and cephalexin (Fig. 3) . The cell viability is reduced to 0.002% when these cells are exposed to one loading and three maintenance doses of tobramycin and cephalexin (Fig. 3) . Unfortunately, complete eradication of the infecting pathogen is not observed even when the antibiotic exposure is continued for an extra 6 days (Fig. 3) . Regrowth of the organism is observed when the antibiotic exposure is terminated. It is clear that the loading and maintenance doses of tobramycin and cephalexin are not sufficient to eradicate the sessile bacteria completely. These doses of antibiotics are only sufficient to reduce the population of planktonic and biofilm cells to a level which curtails the clinical symptoms of infection. We believe that the in vitro chemostat system described in this study will enable health care professionals to determine the antibiotic dosing and also the frequency of antibiotic administration more accurately so that biofilm cells can be eradicated effectively. The system may also be used by pharmaceutical industries in the search for compounds with excellent activities against bacteria in biofilms. A chemostat system has recently been developed to investigate the interaction of planktonic cells of mixed populations of oral pathogens with antibiotics (19) .
Antibiotic manufacturers invest millions of dollars annually to provide valuable information to health care professionals so that they can use antibiotics successfully in killing bacterial pathogens. We believe that the system described in 
